Comparison

K1 cells

Item no. C0025003
Manufacturer Addexbio
Amount One Frozen vial
Category
Type Tumour Cells
Specific against Human (Homo sapiens)
Dry ice Yes
Citations 1.Yuan, G. B., Kuang, A. R., Fan, Q., Yu, L. B., and Mi, Y. X. Combined effects of all-trans-retinoic acid and trichostatin A on the induction of differentiation of thyroid carcinoma cells K1. Chin J Cancer, 29: 379-384.
2.Liu, D., Hou, P., Liu, Z., Wu, G., and Xing, M. Genetic alterations in the phosphoinositide 3-kinase/Akt signaling pathway confer sensitivity of thyroid cancer K1 cells to therapeutic targeting of Akt and mammalian target of rapamycin. Cancer Res, 69: 7311-7319, 2009.
3.Hibma, M. H., Real, N. C., Wiles, A., Dobson-Le, D., Dix, B. R., Wynford-Thomas, D., Braithwaite, A. W., and Royds, J. A. Increased apoptosis and reduced replication efficiency of the E3 region-modified dl309 adenovirus in K1 cancer cells. Virus Res, 145: 112-120, 2009.
4.Schweppe, R. E., Kerege, A. A., Sharma, V., Poczobutt, J. M., Gutierrez-Hartmann, A., Grzywa, R. L., and Haugen, B. R. Distinct genetic alterations in the mitogen-activated protein kinase pathway dictate sensitivity of thyroid K1 cancer cells to mitogen-activated protein kinase kinase 1/2 inhibition. Thyroid, 19: 825-835, 2009.
5.Desailloud, R., Sane, F., Caloone, D., and Hober, D. Persistent infection of a carcinoma thyroid K1 cell line with coxsackievirus B. Thyroid, 19: 369-374, 2009.
6.Lavra, L., Ulivieri, A., Rinaldo, C., Dominici, R., Volante, M., Luciani, E., Bartolazzi, A., Frasca, F., Soddu, S., and Sciacchitano, S. Gal-3 is stimulated by gain-of-function p53 mutations and modulates chemoresistance in anaplastic K1 thyroid carcinomas. J Pathol, 218: 66-75, 2009.
ECLASS 10.1 32160890
ECLASS 11.0 32160890
UNSPSC 41106509
Available
Description

Disease:

Thyroid carcinoma

Origin:

Derived from a primary papillary thyroid carcinoma, but retains thyroid follicular cell differentiation

Species:

Homo sapiens

Tissue:

Thyroid gland

Morphology:

Epithelial

Properties:

Adherent

Cytogenic data:

Tumorigenic

Patient:

Medium:

RPMI1640 + 10% FBS, 1x MEM non-essential AA

Subculture:

1:2 to 1:4 using 0.25% trypsin or trypsin/EDTA, 5% CO2; 37C

Freezing Medium:

Complete culture medium supplemented with 5% (v/v) DMSO

Biosafety Level:

I

Sterility:

Bacteria: Negative

Yeast: Negative

Mycoplasma: Negative

Pathogens:

HIV: Negative

Hepatitis B: Negative

Hepatitis C: Negative

Protein Expression:

Wild-type p53 tumour suppressor gene

Related cells by Organ:

8505C cells

FTC-238 cells

K1 cells

Storage condition
LN2
Manufacturers Category
Cell Lines

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: One Frozen vial
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close